Topiramate Tablet
Product Images NDC 69097-818

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 69097-818). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

A cumulative incidence plot comparing time to first seizure for Topiramate at 50 mg/day versus 400 mg/day over a 500-day period. The graph shows cumulative rates on the y-axis and time in days on the x-axis, indicating seizure occurrence differences between the two dosage groups, with a statistical significance p-value of 0.0002.*

FDA Label Image

Table 12: Efficacy Results In Double-blind, Placebo-controlled, Add-on Epilepsy Trials (Topiramate Fig2)

A bar chart comparing the change from baseline to double-blind phase in average monthly migraine rates for placebo and Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The chart shows results from two studies, Study 10 and Study 11, with statistical significance indicated for Topiramate doses 100 mg/day and 200 mg/day.*

FDA Label Image

Topiramate Fig3 Inv

Label for Topiramate Tablets USP 25 mg oral tablets, containing 60 tablets. The label includes storage instructions and manufacturer details: manufactured by InvaGen Pharmaceuticals, Inc. and for Cipla USA, Inc. The label features NDC 69097-816-03 and states Rx Only with a barcode and QR code.*

FDA Label Image

Topiramate Fig4 Inv

Label of Topiramate Tablets, USP 50 mg oral tablets, manufactured by InvaGen Pharmaceuticals, Inc. and labeled for Cipla USA Inc. The container holds 60 tablets. The label includes storage instructions at 20° to 25°C (68° to 77°F) and advises dispensing with an attached medication guide. It also displays the NDC number 69097-817-03, a barcode, and a QR code.*

FDA Label Image

Topiramate Fig5 Inv

Label of Topiramate Tablets, USP 100 mg oral tablets by Cipla USA Inc. The label indicates a package containing 60 tablets, with instructions to dispense with an attached medication guide. Storage instructions specify 20° to 25°C (68° to 77°F) and protection from moisture. The label features a barcode and manufacturing details for InvaGen Pharmaceuticals, a Cipla Ltd. subsidiary.*

FDA Label Image

Topiramate Fig6 Inv

Topiramate Tablets USP 200 mg oral tablets label by Cipla USA Inc., package containing 60 tablets. The label includes dosing information, storage instructions between 20° to 25°C, and manufacturer details listing InvaGen Pharmaceuticals, Inc., a Cipla Ltd. subsidiary, and Cipla USA, Inc. Barcode and QR code are visible along with lot and expiration placeholders.*

FDA Label Image

Chemical Structure (Topiramate Str)

Chemical structure of Topiramate, illustrating its molecular composition and arrangement of atoms including oxygen, sulfur, nitrogen, carbon, and hydrogen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.